January 2026 Journal Watch
Published 26 January 2026
The first Journal Watch of 2026 explores topics in transplant pharmacy. Issue editor Colleen Hutchinson, PharmD, BCCP, gathers topics including:
- The NUDT16 genotype, and if it predicts development of neutropenia in lung transplant recipients receiving valganciclovir for CMV
- Daratumumab monotherapy: can it desensitize patients awaiting heart transplant?
- Early mammalian target of rapamycin inhibitor (mTORi) initiation with reduced tacrolimus for renal sparing in heart transplant recipients
Issue Junior Editor:
Colleen Hutchinson, PharmD, BCCPCleveland Clinic
Cleveland, OH USA
Contributors:
Xinqi Liu, PharmD, BCTXP
Thomas Jefferson University Hospital
Philadelphia, PA USA
Kevin Reininger, PharmD, BCTXP
Mayo Clinic
Phoeniz, AZ USA
Devi Surajbali, PharmD
Tampa General Hospital
Tampa, FL USA
Journal Watch Senior Editor
Ross Thomson, BA, BMBCh, MRCP

